Evidence map›Paper›PMID 30618811›Full record

ArticleFrontiers in physiology2018

Review on Chamber-Specific Differences in Right and Left Heart Reactive Oxygen Species Handling.

Klaus-Dieter Schlüter, Hanna Sarah Kutsche, Christine Hirschhäuser, Rolf Schreckenberg, Rainer Schulz

Abstract read
In one paragraph

Article in Frontiers in physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Evaluation and Management of Sepsis in Pulmonary Hypertension.Journal of intensive care medicine · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Mitochondrial Integrity Is Critical in Right Heart Failure Development.International journal of molecular sciences · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Mitochondrial Monoamine Oxidase: Another Player in Pulmonary Hypertension?American journal of respiratory cell and molecular biology · 2021
    Article
  19. Article
  20. Cardioprotection in right heart failure.British journal of pharmacology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Klaus-Dieter SchlüterDepartment of Physiology, Justus-Liebig-University Giessen, Giessen, Germany.
Hanna Sarah KutscheDepartment of Physiology, Justus-Liebig-University Giessen, Giessen, Germany.
Christine HirschhäuserDepartment of Physiology, Justus-Liebig-University Giessen, Giessen, Germany.
Rolf SchreckenbergDepartment of Physiology, Justus-Liebig-University Giessen, Giessen, Germany.
Rainer SchulzDepartment of Physiology, Justus-Liebig-University Giessen, Giessen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species (ROS) exert signaling character (redox signaling), or damaging character (oxidative stress) on cardiac tissue depending on their concentration and/or reactivity. The steady state of ROS concentration is determined by the interplay between its production (mitochondrial, cytosolic, and sarcolemmal enzymes) and ROS defense enzymes (mitochondria, cytosol). Recent studies suggest that ROS regulation is different in the left and right ventricle of the heart, specifically by a different activity of superoxide dismutase (SOD). Mitochondrial ROS defense seems to be lower in right ventricular tissue compared to left ventricular tissue. In this review we summarize the current evidence for heart chamber specific differences in ROS regulation that may play a major role in an observed inability of the right ventricle to compensate for cardiac stress such as pulmonary hypertension. Based on the current knowledge regimes to increase ROS defense in right ventricular tissue should be in the focus for the development of future therapies concerning right heart failure.

Indexed as

cardiac remodelingheart failureMAOoxidative stresspulmonary hypertensionuncoupling protein

Identifiers

PMID30618811
PMCPMC6304434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.